The drug that might force the animal feed sector to rethink its approach

GLP-1 inhibitors such as Ozempic, which reduce appetite and cut calorie intake by 20% (approx. 800 kilocalories daily), are transforming global eating habits. This poses a significant challenge to the livestock feed and additives industry, says Aidan Connolly, president of AgriTech Capital LLC. Originally developed for diabetes, these medications are encouraging consumers to opt for lean proteins and avoid fatty, processed foods. With 15.5 million US adults currently using these medications a